I 13.5 Pill - white round, 9mm
Generic Name: pemigatinib
Pill with imprint I 13.5 is White, Round and has been identified as Pemazyre 13.5 mg. It is supplied by Incyte Corporation.
Pemazyre is used in the treatment of Cholangiocarcinoma; Myeloid/Lymphoid Neoplasms and belongs to the drug class multikinase inhibitors. Pemazyre 13.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I 13.5
Pemazyre
- Generic Name
- pemigatinib
- Imprint
- I 13.5
- Strength
- 13.5 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0028
Related images for "I 13.5"
More about Pemazyre (pemigatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.